Clinical data | |
---|---|
Other names | N,N-Methylallyltyptamine; (2-(1H-Indol-3-yl)ethyl)(methyl)(prop-2-en-1-yl)amine; 1H-Indole-3-ethanamine, N-methyl-N-2-propen-1-yl-; Malt |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C14H18N2 |
Molar mass | 214.312 g·mol−1 |
3D model (JSmol) | |
| |
|
MALT (N-methyl-N-allyltryptamine or N,N-methylallyltryptamine) is a lesser-known drug from the tryptamine family. It is a novel compound with very little history of human use. It is closely related to methylpropyltryptamine (MPT), as well as N-methyltryptamine. It has been sold online as a designer drug. Very little information on the pharmacology or toxicity of MALT is available.
Legality
MALT is not explicitly scheduled in any countries; however, it could be considered a psychoactive substance under the UK Psychoactive Substances Act, which requires the prosecutor to prove that the substance is psychoactive in order for a person to be charged with an offense.[1]
It could also be considered a structural analog of a scheduled substance under the US Federal Analogue Act due to its similarity to scheduled tryptamines.
See also
- 5-Methoxy-N,N-Methylallyltryptamine (5-MeO-MALT)
- N,N-Diallyltryptamine (DALT)
- Methylpropyltryptamine (MPT)
References
- ↑ "Psychoactive Substances Act Guidance" (PDF). The Crown Prosecution Service. Retrieved 2021-09-23.
Further reading
- Chadeayne AR, Pham DN, Golen JA, Manke DR (August 2020). "DMT analogues: N-ethyl-N-propyl-tryptamine and N-allyl-N-methytryptamine as their hydro-fumarate salts". Acta Crystallographica Section E: Crystallographic Communications. 76 (Pt 8): 1201–1205. doi:10.1107/S2056989020008683. PMC 7405555. PMID 32843999.
- Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (November 2004). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS". The Analyst. 129 (11): 1047–1057. Bibcode:2004Ana...129.1047B. doi:10.1039/b407239c. PMID 15508033.
5-HT1 |
| ||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-HT2 |
| ||||||||||||||||||||||||||||||||||||||
5-HT3–7 |
| ||||||||||||||||||||||||||||||||||||||
|
|